论文部分内容阅读
目的 评价纤维支气管镜 (纤支镜 )支气管肺泡灌洗 (BAL)对急性脑血管病 (ACVD)病人医院获得性肺炎 (HAP)的疗效。方法 15 0例ACVD HAP病例随机分为常规治疗组及灌洗治疗组 ,参照“卒中病人临床神经功能缺损程度评分标准”对两组病人入院时及病程 2 8d先后评分、两组间的死亡、恶化及康复病例数进行分析、对比。结果 死亡及恶化病例灌洗治疗组为 34 7%、常规治疗组为 73 4 % ,两组间差异有非常显著意义 (P <0 0 1)。康复病例灌洗治疗组为 6 5 3%、常规治疗组为 2 6 6 % ,差异有非常显著意义 (P <0 0 1)。结论 对ACVD HAP病人行纤支镜BAL ,有利于通畅呼吸道 ,明确病原菌及指导正确选用抗生素 ,迅速控制HAP ,促进脑损害的康复 ,达到减少ACVD病死率的效果
Objective To evaluate the efficacy of bronchial alveolar lavage (BAL) with bronchoscopy (bronchoscopy) on hospital acquired pneumonia (HAP) in patients with acute cerebrovascular disease (ACVD). Methods Fifty cases of ACVD HAP were randomly divided into routine treatment group and lavage treatment group. According to the standard score of clinical neurological deficit in stroke patients, the two groups were scored on admission and on the course of 28 days. The death, Deterioration and the number of cases of rehabilitation for analysis, comparison. Results The number of deaths and exacerbations was 34.7% in the lavage treatment group and 73.4% in the conventional treatment group. There was a significant difference between the two groups (P <0.01). In the recovery group, the rate of lavage treatment group was 65.3% and that of the conventional treatment group was 26.6%, the difference was significant (P <0.01). Conclusions The bronchoalveolar lavage fluid (BAL) in patients with ACVD HAP is conducive to clear the respiratory tract, clarify the pathogens and guide the correct selection of antibiotics, to quickly control HAP and promote the recovery of brain damage, and to reduce the ACVD mortality rate